TOCQUEVILLE ASSET MANAGEMENT L.P. - CHAMPIONS ONCOLOGY INC ownership

CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 47 filers reported holding CHAMPIONS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of CHAMPIONS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$4,132,308
-2.7%
665,4280.0%0.08%
+2.6%
Q2 2023$4,245,431
+58.7%
665,4280.0%0.08%
+49.0%
Q1 2023$2,675,021
-3.6%
665,428
+8.2%
0.05%
-3.8%
Q4 2022$2,774,678
+8.3%
615,228
+80.1%
0.05%
+1.9%
Q3 2022$2,562,000
+11.7%
341,666
+19.2%
0.05%
+23.8%
Q2 2022$2,293,000
+11.7%
286,611
+13.5%
0.04%
+35.5%
Q1 2022$2,053,000
-2.7%
252,4610.0%0.03%
+6.9%
Q4 2021$2,111,000
-18.1%
252,4610.0%0.03%
-23.7%
Q3 2021$2,578,000
-0.7%
252,4610.0%0.04%
+2.7%
Q2 2021$2,595,000
-9.0%
252,4610.0%0.04%
-15.9%
Q1 2021$2,853,000
+4.7%
252,4610.0%0.04%
-2.2%
Q4 2020$2,724,000
+16.7%
252,4610.0%0.04%0.0%
Q3 2020$2,335,000
-3.3%
252,4610.0%0.04%
-10.0%
Q2 2020$2,414,000
+29.2%
252,4610.0%0.05%
+8.7%
Q1 2020$1,868,000
+9.6%
252,461
+23.4%
0.05%
+84.0%
Q4 2019$1,704,000
+124.2%
204,568
+52.0%
0.02%
+150.0%
Q3 2019$760,000
+22.0%
134,568
+69.1%
0.01%
+25.0%
Q2 2019$623,000
-20.0%
79,5680.0%0.01%
-20.0%
Q1 2019$779,000
+25.4%
79,5680.0%0.01%
+11.1%
Q4 2018$621,000
-60.3%
79,568
-11.2%
0.01%
-55.0%
Q3 2018$1,565,000
+114.7%
89,568
-22.1%
0.02%
+122.2%
Q2 2018$729,000114,9510.01%
Other shareholders
CHAMPIONS ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Battery Management Corp. 2,421,673$26,130,0006.61%
Roubaix Capital, LLC 206,502$2,228,0001.72%
Millrace Asset Group, Inc. 182,337$1,967,0001.37%
NEA Management Company, LLC 1,713,720$18,491,0000.49%
Zebra Capital Management LLC 32,084$346,0000.44%
Overbrook Management Corp 101,445$1,095,0000.27%
EAM Investors, LLC 99,763$1,076,0000.18%
Aristides Capital LLC 40,000$432,0000.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,232$974,0000.12%
Cowen Prime Services LLC 13,500$146,0000.06%
View complete list of CHAMPIONS ONCOLOGY INC shareholders